Trade Summary

2 days ago, Fordyce Marshall, serving as Pres, CEO at Vera Therapeutics, Inc. (VERA), sold 18,500 shares at $36.74 per share, for a total transaction value of $679,747.00. Following this transaction, Fordyce Marshall now holds 438,774 shares of VERA.

This sale represents a 4.00% decrease in Fordyce Marshall's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, May 12, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 13, 2026, 1 day after the trade was made.

Vera Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.